Yervoy Logo
Nov. 23, 2024
Yervoy – Vivo Infusion Therapy OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Safety Profile for mNSCLC Important News for Pathologists Owler Reports - Press Release: YERVOY : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Shows Promising Results in Patients with Advanced Form of Bladder Cancer 1L MPM & NSCLC Treatment | OPDIVO® (nivolumab) + YERVOY® (ipilimumab) Home | Yervoy Logo